Jaguar Health, Inc. (JAGX)
4.78
+0.25
(+5.52%)
USD |
NASDAQ |
Oct 09, 16:00
4.85
+0.07
(+1.46%)
After-Hours: 20:00
Jaguar Health Gross Profit Margin (Quarterly) : -22.04% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.04% |
| March 31, 2026 | 91.99% |
| December 31, 2025 | 15.21% |
| September 30, 2025 | 64.58% |
| June 30, 2025 | 63.65% |
| March 31, 2025 | 52.08% |
| December 31, 2024 | 67.23% |
| September 30, 2024 | 63.42% |
| June 30, 2024 | 63.76% |
| March 31, 2024 | 55.76% |
| December 31, 2023 | 44.43% |
| September 30, 2023 | 70.62% |
| June 30, 2023 | 58.45% |
| March 31, 2023 | 54.56% |
| December 31, 2022 | 75.58% |
| September 30, 2022 | 80.54% |
| June 30, 2022 | 62.20% |
| March 31, 2022 | 65.33% |
| December 31, 2021 | 65.62% |
| September 30, 2021 | 2.06% |
| June 30, 2021 | -72.47% |
| March 31, 2021 | 53.02% |
| December 31, 2020 | 69.37% |
| Date | Value |
|---|---|
| September 30, 2020 | 71.73% |
| June 30, 2020 | 67.45% |
| March 31, 2020 | 22.21% |
| December 31, 2019 | 50.69% |
| September 30, 2019 | -13.11% |
| June 30, 2019 | 26.11% |
| March 31, 2019 | 45.59% |
| December 31, 2018 | 40.04% |
| September 30, 2018 | -2.32% |
| June 30, 2018 | -16.50% |
| March 31, 2018 | 40.43% |
| December 31, 2017 | 50.08% |
| September 30, 2017 | 67.12% |
| June 30, 2017 | 95.56% |
| March 31, 2017 | 96.21% |
| December 31, 2016 | -4.50% |
| September 30, 2016 | 50.60% |
| June 30, 2016 | 24.48% |
| March 31, 2016 | 31.23% |
| December 31, 2015 | 35.51% |
| September 30, 2015 | 52.77% |
| June 30, 2015 | 73.22% |
| March 31, 2015 | 45.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | 96.50% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.88% |
| Return on Invested Capital | -131.5% |
| Profit Margin (Quarterly) | -1.05K% |
| Operating Margin (Quarterly) | -620.2% |
| Return on Net Operating Assets | -133.5% |